Lipella Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 14 May 24 | BuyUS$7,590 | Jonathan Kaufman | Individual | 1,250 | US$6.07 | |
| 19 Mar 24 | BuyUS$45,452 | Jonathan Kaufman | Individual | 6,875 | US$6.98 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 46,528 | 3.85% |
| Individual Insiders | 355,123 | 29.4% |
| General Public | 807,303 | 66.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 66.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 112,356 | US$271.9k | 0% | no data | |||
| 109,705 | US$265.5k | 0% | no data | |||
| 69,445 | US$168.1k | 0% | no data | |||
| 63,617 | US$154.0k | 0% | no data | |||
| 35,931 | US$87.0k | 0% | no data | |||
| 4,315 | US$10.4k | 0% | no data | |||
| 3,114 | US$7.5k | -4.16% | no data | |||
| 2,202 | US$5.3k | 0% | no data | |||
| 961 | US$2.3k | -0.31% | no data | |||
| 5 | US$12.0 | 0% | no data |